PLSE stock forecast
Our latest prediction for Pulse Biosciences, Inc.'s stock price was made on the May 11, 2018 when the stock price was at 15.19$.
In the short term (2weeks), PLSE's stock price should outperform the market by 4.37%. During that period the price should oscillate between -9.81% and +16.13%.
In the medium term (3months), PLSE's stock price should outperform the market by 4.79%. During that period the price should oscillate between -20.84% and +35.46%.Get email alerts
Create a solid portfolio with PLSE
About Pulse Biosciences, Inc.
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.23$ per share.
The book value per share is 2.08$
Three months stock forecastMay 11, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|